Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis

Diagn Cytopathol. 2000 Dec;23(6):369-74. doi: 10.1002/1097-0339(200012)23:6<369::aid-dc1>3.0.co;2-3.

Abstract

Flow cytometric immunophenotypic analysis (FCA) can be performed to evaluate lymphoid cells in cerebrospinal fluid (CSF). We compared this method with conventional cytologic diagnosis to determine its utility. A retrospective comparison of 35 consecutive CSF flow cytometry results with the corresponding cytologic diagnoses was undertaken. Twenty-five of 35 CSFs (71%) were successfully analyzed by flow cytometry. The 10 samples which could not be analyzed were either too old (greater than 3 days) or had an insufficient number of cells. A total of 9 lymphomas was detected: 4 by both flow cytometry and cytology; 2 by cytology alone; and 3 by flow cytometry alone. This represents a 50% increase in the detection of lymphoproliferative disorders in CSF by a combination of flow cytometry and cytology vs. cytology alone. Furthermore, in 3 cases with follow-up where the cytologic diagnosis was "atypical cells of undetermined significance" and the flow cytometric findings were negative for malignancy, the clinical course confirmed a benign pleocytosis in all three. We conclude that flow cytometric analysis markedly improves sensitivity when used in combination with cytology in the evaluation of lymphoid cells in CSF.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Biomarkers, Tumor / chemical synthesis
  • Cerebrospinal Fluid / cytology
  • Cytodiagnosis / methods
  • Flow Cytometry / methods*
  • Humans
  • Immunophenotyping
  • Lymphoproliferative Disorders / cerebrospinal fluid*
  • Lymphoproliferative Disorders / pathology
  • Reproducibility of Results
  • Retrospective Studies
  • Sensitivity and Specificity

Substances

  • Biomarkers, Tumor